Introduction
Amidst the unprecedented challenges posed by the global health crisis brought about by the COVID-19 pandemic, the spotlight shines brightly on the critical aspects of global vaccine sharing and the obligations incumbent upon pharmaceutical companies to address the worldwide scarcity of vaccines. Central to the resolution of this crisis is the essential examination of the profound impact of global vaccine sharing and the intricate web of responsibilities that pharmaceutical companies must shoulder in this pivotal mission.